Determining the Risk of Recurrence in HR+/HER2- Early Breast Cancer Without Axillary Dissection

Determining the Risk of Recurrence in HR+/HER2- Early Breast Cancer Without Axillary Dissection

Released Friday, 28th February 2025
Good episode? Give it some love!
Determining the Risk of Recurrence in HR+/HER2- Early Breast Cancer Without Axillary Dissection

Determining the Risk of Recurrence in HR+/HER2- Early Breast Cancer Without Axillary Dissection

Determining the Risk of Recurrence in HR+/HER2- Early Breast Cancer Without Axillary Dissection

Determining the Risk of Recurrence in HR+/HER2- Early Breast Cancer Without Axillary Dissection

Friday, 28th February 2025
Good episode? Give it some love!
Rate Episode

How does lymph node assessment play a pivotal role in personalized, multidisciplinary care?

Credit available for this activity expires: 2/24/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002279?ecd=bdc_podcast_libsyn_mscpedu

Show More
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features